Abstract
Clinical researches including the Mayo Anesthesia Safety in Kids (MASK) study have found that children undergoing multiple anesthesia may have a higher risk of fine motor control difficulties. However, the underlying mechanisms remain elusive. Here, we report that erythropoietin receptor (EPOR), a microglial receptor associated with phagocytic activity, was significantly downregulated in the medial prefrontal cortex of young mice after multiple sevoflurane anesthesia exposure. Importantly, we found that the inhibited erythropoietin (EPO)/EPOR signaling axis led to microglial polarization, excessive excitatory synaptic pruning, and abnormal fine motor control skills in mice with multiple anesthesia exposure, and those above-mentioned situations were fully reversed by supplementing EPO-derived peptide ARA290 by intraperitoneal injection. Together, the microglial EPOR was identified as a key mediator regulating early synaptic development in this study, which impacted sevoflurane-induced fine motor dysfunction. Moreover, ARA290 might serve as a new treatment against neurotoxicity induced by general anesthesia in clinical practice by targeting the EPO/EPOR signaling pathway.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Advances in modern general anesthesia (GA) have guaranteed the successful implementation of millions of surgeries every year [1]. However, concerns have been raised about whether general anesthetic agents cause deleterious effects on the central nervous system (CNS). Animal studies have identified Alzheimer-like disease processes [2], cognitive dysfunction [3], autism [4], learning deficits [5]. and fine motor abnormalities [6, 7] in the brain receiving repeated general anesthesia. A secondary analysis based on the MASK study also concluded that exposure to multiple procedures with general anesthesia was associated with decreases in fine motor skills in subjects [8]. Subsequently, a number of studies from rodents to humans including non-human primates were motivated to focus on the issue of anesthesia-induced fine motor deficits [7, 9].
Sevoflurane is a commonly used anesthetic in pediatrics, which has been implicated in causing neurotoxic risks in immature animals and humans [10, 11]. A repeated sevoflurane exposure (3 consecutive 2-hour sections at P6-8 in mice) model has been established to induce motor dysfunctions in rodents [7]. Diverse cellular and molecular changes causing synaptic damage have been implicated in the pathogenesis [12], in which intervention target (s) might be found to aid the development of a potential drug for the treatment of GA-induced neurotoxicity. Reportedly, neuroinflammation driven by microglia is one of the primary culprits for synaptic loss in multiple developing diseases including depression [13] and anxiety-like behavior [12]. Microglia are well-described mediators that shape synaptic plasticity through their phagocytosis properties. Prior studies have indicated that a pro-inflammatory state triggered aberrant synaptic phagocytosis of microglia in the developing brain, causing abnormalities in brain functions [14]. However, whether and how sevoflurane exposure resulted in this pathological process remains unclear. Neuropsychological and imaging studies have indicated that excitatory neurons in the medial prefrontal cortex (mPFC) are critical for the regulation of fine motor [15, 16]. Hence, exploring the molecular mechanism of anesthesia-induced loss and damage of excitatory synapses with aberrant pruning of microglia in the mPFC is an appealing concept. Brain-derived EPO is a key anti-inflammatory mediator exerting neuroprotective effects via EPOR that is expressed on microglia [17]. The EPO derivative ARA290 is a widely used drug preventing neuroinflammation in multiple diseases, such as brain and peripheral nerve injury [18, 19]. We hypothesized that EPO/EPOR system in the mPFC-mediated sevoflurane-induced fine motor deficits and supplementation of the EPO derivative ARA290 could attenuate sevoflurane-induced microglia proinflammatory activation alleviated, excessive synaptic pruning and synaptic deficiency, and improved fine motor impairments in mice.
Here, we identify that inhibition of EPO/EPOR-janus kinase 2 (JAK2)-signal transducer and activator of transcription 3 (STAT3) signaling pathway mediates microglial activation and excessive synaptic phagocytosis after repeated sevoflurane exposure, resulting in impairment in fine motor coordination in mice. We further showed that injection of the EPO derivative ARA290 significantly attenuated microglia proinflammatory activation, alleviated excessive synaptic pruning and synaptic deficiency, and significantly improved fine motor impairment in the repeated sevoflurane exposed mice. Together, our results uncover the molecular signaling that regulates repeated exposure to sevoflurane-induced fine motor dysfunction, and we speculate that ARA290 might be an efficient supplementation to sevoflurane-induced fine motor deficits in clinical conditions.
Materials and Methods
Animals
Adult C57BL/6 mice were purchased from the Animal Center of the Fourth Military Medical University and raised in a standard environment with a temperature of 22–25°C, a humidity of 50%, and a 12-h/12-h light/dark cycle. 5–6 mice were reared in each cage and allowed ad libitum access to food and water. After housing male and female mice together, the pregnant females were isolated and fed till their delivery. The newborn pups (including both males and females) were used for studies. All experimental procedures were performed following the institutional guidelines and approved by the Animal Care and Use Committee of the Fourth Military Medical University.
Mice Treatments
Newborn C57BL/6 mice were randomly divided on the 6th day after birth (P6) into the following groups. (1) Control (Ctl) group: mice inhaled 60% oxygen (balanced with nitrogen) for 2 hours every day for three days in a row. (2) Sevoflurane (Sev) group: Mice inhaled 3% sevoflurane (Cat#: H20110142, Baxter) + 60% oxygen (balanced with nitrogen) for 2 h/day for three days in a row. (3) Ctl+PBS group: mice inhaled 60% oxygen (balanced with nitrogen) for 2 hours every day and intraperitoneally injected 50 μL PBS (Cat#: PC-00003, Plant Chem Med) for three days in a row. (4) Sev+PBS group: Mice received 3% sevoflurane exposure and were treated with an intraperitoneal injection of 50 μL PBS for three days in a row. (5) Sev+ARA290 group: Mice were intraperitoneally injected with 50 μL ARA290 (30 μg/kg) (Cat#: PC-49529, Plant Chem Med) after sevoflurane anesthesia. The model mice were placed separately in a rectangular transparent sealed Plexiglas container (length × width × height = 25 cm × 12 cm × 10 cm), which was connected to an oxygen and/or sevoflurane catheter, and a warm blanket was placed at the bottom to maintain body temperature. The respiration and skin color of mice were constantly observed during the molding process. After completing the modeling, neonatal mice were quickly placed back next to the dams. All procedures were performed from 9:00 to 11:00 AM on the day.
Golgi Staining
The abovementioned mice were anesthetized by intraperitoneal injection of pentobarbital sodium (150 mg/kg) and perfused with PBS at P60. Mouse brains were dissected and soaked in Golgi dyeing liquor containing 50% potassium dichromate (Cat#: 021563389, MP Biomedicals), 5% mercury chloride (Cat#: M1136, Sigma Aldrich), and 5% potassium chromate (Cat#: 529508, Sigma Aldrich). After 6 days of protecting light, 150 μm brain slices were prepared and rinsed with distilled water, dehydrated with ethanol, and then treated with ammonia (3:1). Next, slices were rinsed and hatched with 5% sodium thiosulfate for 10 min, followed by dehydration with graded ethanol and clarification with xylene. The completed slices were observed under the bright field of view of the Olympus FV1000. The images were captured by z-stack scanning with an excitation wavelength of 405 nm. Sholl analysis was conducted on the branching of dendrites. Imaris software (version 8.4.1, Bitplane) was applied to rebuild the dendrite axis and dendritic spine of pyramidal neurons in the mPFC.
Transmission Electron Microscopy
Mice were anesthetized by intraperitoneal injection of pentobarbital sodium (150 mg/kg) and perfused with physiological saline (Cat#: 2205200721, CISEN) and then postfixed with 4% polyformaldehyde mixture including 1% glutaraldehyde. Histologic slices of 50 μm were prepared using a vibratome (VT1000 S, Leica) and then fastened with 1% osmium tetroxide, dewatered with gradient ethanol, treated with propylene oxide, and embedded in Epon 812 (SPI-Chem). Ultrathin slices (70–80 nm) were ready on an ultramicrotome (EMUC6, Leica), fixed on mesh grids (6–8 slices per grid). After redying with uranyl acetate and lead citrate, the sections were observed under JEM-1230 electron microscopy (JEOL), and synaptic images were collected.
Western Blot
The brain tissue (mPFC) was homogenized in RIPA lysis buffer (0.5% NP-40, 150 mmol/L NaCl, 1 mmol/L EDTA, 10 mmol/L Tris, and 1% Triton X-100 at pH7.4) including protease (Cat#: 43002700, Roche) and phosphatase inhibitor (Cat#: 41659200, Roche). The concentration of protein was measured by BCA assay (Cat#: 23225, Thermo Scientific). After separation by 10% or 12% SDS-PAGE, the protein was deflected to 0.22 μm polyvinylidene fluoride membranes (Cat#: 03010040001, Roche Diagnostics Gmbh), blockaded with TBS including 5% skim milk and 0.1% Tween 20, and hatched with the primary antibodies overnight at 4°C as shown below: mouse anti-β-actin (1:5000, GeneTex#11003), rabbit anti-β-actin (1:5000, GeneTex#109639), rabbit anti-iNOS (1:1000, proteintech#18985-1-AP), rabbit anti-Arginase-1 (1:2000, proteintech#16001-1-AP), rabbit anti-IL-1β (1:1000, CST#31202s), rabbit anti-LAMP1 (1:1000, proteintech#21997-1-AP), mouse anti-CD68 (1:1500, Bio-Rad#MCA1957), rabbit anti-EPOR (1:1000, GeneTex#37704), mouse anti-EPO (1:200, Santa Cruz#5290), rabbit anti-p-JAK2 (1:500, CST#3771), rabbit anti-JAK2 (1:1000, CST#3230), rabbit anti-p-STAT3 (1:1000, CST#9145), rabbit anti-STAT3 (1:1000, GeneTex#636400), goat anti-Iba1 (1:1000, abcam#5076), rabbit anti-HIF2α (1:1000, abcam#109616). After washing with TBST, the membranes were hatched with HRP-conjugated anti-rabbit (1:5000, Proteintech#SA00001-2), anti-mouse (1:5000, Proteintech#SA00001-1), and anti-goat (1:5000, Proteintech#SA00001-4), respectively at room temperature for 2 hours. The bands were displayed with the ECL reagent kit (Cat#: 32106, Thermo). The grayscale value was quantified by ImageJ to determine the level of target proteins relative to β-actin.
Immunostaining
Mice were anesthetized by intraperitoneal injection of pentobarbital sodium (150 mg/kg) and transcardially perfused with saline followed by 4% paraformaldehyde (PFA). Brains were dissected, fixed for 4 h in 4% PFA, and kept in 30% sucrose at 4 °C until the brain sank to the bottom of the container. Serial coronal 25 μm slices were prepared and blockaded by PBS including 3% BSA and 0.3% Triton-X100 and then hatched with primary antibodies overnight at 4 °C as shown below: rabbit anti-Iba1 (1:800, Wako Chemicals#019-19741), guinea-pig anti-VGlut2 (1:200, Synaptic Systems#135404), mouse anti-CD68 (1:500, Biolegend#137001). After washing with PBS, the reciprocal secondary antibodies conjugated with Alexa Fluro 488 (donkey anti-rabbit) or Alexa Fluro 594 (donkey anti-mouse) were incubated with the slices at room temperature in the dark for 2 h. After washing with PBS, the slices were redyed with Hoechst (1:1000, Sigma#33324) for 15 min. Fluorescent images were acquired using a confocal microscope (Olympus Fluoview Ver4.2 b) with a 20×, 40× or 100× oil objective. All images were taken from the mPFC.
Dual Fluorescence in situ Hybridization and Immunofluorescence Staining
Fluorescent in situ hybridization was conducted using the RNAscope Multiplex Fluorescent V2 Assay kit (Cat#: 323100, ACD) in line with the manufacturer’s instructions on the brain slices. EPOR (Cat#: 412351, ACD) probes were applied in the current research. In situ hybridization was followed by immunofluorescence staining, as described above, by using rabbit anti-Iba1 (Cat#: 019-19741, Wako Chemicals), rabbit anti-NeuN (1:800, Millipore#ABN78) and rabbit anti-S100β (1:100, abcam#ab52642). Alexa Fluor 488 Goat anti-rabbit IgG (Cat#: 706585148, Jackson immunoresearch) secondary antibody was applied in dual fluorescence in situ and immunofluorescence staining.
3D Reconstruction of Images and Synapse Engulfment Quantification
Z-stacks encompassing high-magnification images were collected on a Zeiss laser scanning confocal microscope with a 100x objective using 0.5 µm z steps. Laser power and gain were consistent across all experiments. For each hemisphere, at least 8 fields were imaged. Subsequently, all channels of images were subjected to background subtraction and Gaussian filtering using IMARIS 9.3.1 software (Bitplane). Then, 3D volume surface renderings were created. For the analysis of microglia-synapse engulfment, a threshold was selected to include as many of the processes as possible while excluding any background, and a 0.01 µm3 size filter was applied. The automatic threshold calculated in Imaris based on k-means statistical methods was used in the majority of analyses. Then, presynaptic VGlut2+ boutons were reconstructed as ‘‘spots’’ of 0.8 mm diameter (corresponding to the largest measured size of presynaptic boutons) and their total number was automatically calculated. Next, the number of spots located at no more than 0.5 mm from the microglia surface was automatically determined and indicated as a contact. The 0.5 mm distance was calculated from the center of mass of the reconstructed ‘‘spot’’. It corresponded to its radius thus identifying as contact only those spots that were completely juxtaposed to the surface. In the representative images only contacted boutons were shown as reconstructed spots.
RNA-Seq
Brain tissues (mPFC) from the Ctl and Sev groups on the third day after repeated sevoflurane or oxygen exposure were harvested (n = 3 per group) under RNase-free conditions. Messenger RNA (mRNA) sequencing was conducted by Novogene Co, Ltd (Xi’an, China). Briefly, general RNAs were separated from the mPFC making use of TRIzol Reagent (Cat#: 15596018, Ambion) and then used to build a sequencing library. mRNA was enriched and cleaved into short fragments making use of fragment buffer, followed by reverse transcription into cDNA using random primers. The cDNA fragments were purified, performed end repair, poly (A) tails, and then linked to the Illumina sequencing adapter. Then the linked product was selected by agarose gel electrophoresis, amplified by PCR, and sequenced by Illumina Novaseq6000 (Denovo biotechnology). Differentially expressed genes (DEGs) were evaluated by analyzing differential RNA expressions between two groups. Transcripts with false discovery rate (FDR) parameters below 0.05 and an absolute fold change of 2 or greater were considered differentially expressed. Pathway enrichment analysis was conducted using the Kyoto Encyclopedia of Genes and Genomes (KEGG). The calculated P-value was corrected by FDR, with an FDR of 0.05 or less as the threshold. The pathway that meets this condition was defined as the significantly enriched pathway in DEG.
Quantitative Real-Time PCR
General RNAs from the mPFC were harvested making use of TRIzol (Cat#: 15596018, Ambion) in the light of the manufacturer’s instructions, followed by reverse transcription into cDNA making use of the Prime Script RT Reagent Kit (Cat#: RR036A, TaKaRa). The standard SYBR Green (Cat#: B21202, Bimake) method was applied to test the relative expression of mRNA using a StepOnePlus Real-Time PCR System (Applied Biosystems). The expression of the object gene was standardized to the level of GAPDH. Primers and probes used are listed in Supplemental Table S1.
ELISA
Serum and viscus EPO levels were detected using a commercially available mouse erythropoietin (EPO) ELISA kit (Cat#: F10430, Shanghai Xitang Biotechnology Co.). Briefly, the diluted and standard specimens were added to the well and hatched at 37°C for 90 min. Then, the plate was washed, tested antibodies, and hatched at 37°C for 1 h. The plate was washed again, Avidin-Biotin Peroxidase Complex in every well, and then hatched at 37°C for 30 min. The plate was washed and added color developing reagent. After hatching at 37°C for 15–25 min, the plate was added to the stopping solution and read the optical density at a wavelength of 450 nm. All experiments were duplicated three times. The results of EPO were expressed in concentration as pg/mL.
Gait Analysis
Automated gait assessment tests are used in studies of disorders characterized by gait impairment including fine motor dysfunction [20]. The CatWalkXT® (Version 10.6, Nordus) of the automatic gait analysis system (Nordus Information Technology) is composed of a walkway covered by a tunnel (a 1.3-meter horizontal glass panel). Briefly, the animals walked down a glass aisle while the camera was recording the footprints from beneath. After presupposing camera gain (17.0 dB) and intensity threshold (0.1), no less than 30 runs were recorded for every animal to gain representative runs completed by every animal. When animals walk continuously without stopping on the walkway, a single run is completed. The data captured by CatWalkXT® were semi-automatically analyzed by software. Data on indicators such as paw print area, paw force, and supported paw base were collected. After initial adaptation to the new environment, animals must perform at least three uninterrupted runs to meet the conditions for gait analysis.
Rotarod Test
An accelerating rotarod apparatus was utilized to detect the motor coordination ability of mice. Firstly, mice were trained with 3 trials daily for 3 days. On the first two days, the accelerating speeds were 0-5 r/min and 0–10 r/min within 10 s, respectively. The speed was constantly maintained for 5 min. On the third day, the speed was accelerated from 0-5 r/min within 10 s, then accelerated to 20 r/min within 5 min. The detection stage was on the fourth day. Within 10 s, the speed was accelerated from 0–5 r/min, then accelerated to 40 r/min in 90 s. The speed was constantly maintained for 5 min. If the mice fell in the first three days, they should be placed back on the stick. On the last day, the fall time was recorded and taken as the average.
Statistical Analysis
Data analysis was conducted with GraphPad Prism (Version 8.0) and SPSS software (Version 21.0). The test of normality was conducted with the Shapiro-Wilk test. The homogeneity of variance test was conducted with Levene's test. The data that satisfied these two requirements were analyzed by applying a two-tailed, unpaired, or paired t-test, a one-way ANOVA, or a repeated-measures ANOVA followed by Tukey's multiple-comparison test. The data set with non-normal distribution was analyzed by a non-parametric test. The data were denoted as the mean ± SD. P value less than 0.05 was considered to be statistically significant. Using PASS software (NCSS, LLC) and the results of previous studies [21], the estimated sample size (90% power and α < 0.05 [2-tailed t-test]) is as follows: behavioral test 12 mice per group, EPO ELISA test 12 mice per group, immunostaining 6 mice per group and western blot 3 mice per group. To reduce bias, mice with similar general conditions were randomly assigned to different groups. All experiments and data analyses were strictly conducted to control for information bias. mRNA sequencing and analysis were conducted by blinded investigators.
Results
Repeated Sevoflurane Exposure in Newborn Mice Leads to Long-Lasting Fine Motor Deficits
Gait analysis is an objective tool for evaluating fine motor function in mice [22]. We conducted a gait analysis to evaluate the fine motor function of the mice at P60 (Fig. 1A, B). Results showed that repeated sevoflurane exposure caused a remarkable decrease in walking speed, including cadence, swing speed, and run average speed (Fig. 1C–E). Accordingly, extension in completion and standing time was significantly increased in the Sev group (Fig. 1F–G). There was no remarkable difference in other static indicators, including the base of support-front/hind paws, duty cycle, max contact area, mean intensity, and run maximum variation (Fig. S1A–F). Besides, the rotarod test showed a noticeable decrease in the descending latency in the Sev group (Fig. 1H–I). These results reveal that repeated sevoflurane exposure in newborn mice leads to defects in fine motor in adulthood.
Repeated Sevoflurane Exposure Triggers Microglia Activation and Enhanced Phagocytosis in the mPFC of the Newborn Mice
Microglia, as immune macrophages in the CNS, are prone to morphological changes and transition to an activated state after receiving external stimuli [23]. Morphological changes of microglia in the mPFC were evaluated after repeated sevoflurane exposure (Fig. 2A). We first observed that the expression and fluorescence intensity of Iba1 was not changed in the Sev group (Fig. S1A–D). Then, the stack scanning images of microglia were rebuilt in three dimensions by applying Imaris software (Fig. 2B). We found that on the 3rd day after repeated sevoflurane exposure, the morphology of microglia in the mPFC remarkably changed, including significantly increased soma size (Fig. 2C), decreased branch points (Fig. 2D), reduced process length (Fig. 2E) and declined complexity of branches (Fig. 2F). There were no significant differences in the morphology of microglia at other timepoints (Fig. S1E-G). WB analysis displayed that the expressions of iNOS (M1 markers of microglia activation) (Fig. 2G) and pro-inflammatory factor IL-1β (Fig. 2H–J) in the mPFC were significantly increased, yet the expression of arginase-1 (M2 marker of microglia) (Fig. 2H–I) was downregulated on the 3rd day. Similarly, the mRNA level of the pro-inflammatory factor (IL-1β) was higher (Fig. S1I), while the mRNA level of the anti-inflammatory mediator (arginase-1) was decreased (Fig. S1H). We further observed the phagocytosis of microglia. We assessed whether protein levels of lysosome markers were affected in mice (since phagocytosed particles are ultimately passed to lysosomes for digestion). WB analysis and immunofluorescence displayed that the level of homologous lysosomal marker LAMP1 and microglia lysosomal marker CD68 were significantly increased (Fig. 2K–M), suggesting that repeated sevoflurane exposure in newborn mice enhanced the phagocytic activity of microglia. Together, these data demonstrate that microglia in the mPFC are activated into a pro-inflammatory state and exhibit enhanced phagocytic activity on the 3rd day after repeated sevoflurane exposure.
Repeated Sevoflurane Exposure Caused Hyper-Phagocytosis of Excitatory Synapses in Microglia and Long-Term Synaptic Toxicity
Aberrant microglial phagocytosis could result in impaired pruning of synapses during development [24]. Here, we observed microglial pruning of synapses in the mPFC of the mice (Fig. 3A). We co-labeled the excitatory synapses VGlut2+ with Iba1 and found that microglia in the mPFC pruned significantly more excitatory synapses on the 3rd (P11), 7th (P15), 13th (P21) days after sevoflurane exposure (Fig. 3B, C). The most obvious pruning occurred at P21, but there was no remarkable difference at P30 (Fig. 3D). To verify the effect of microglia synaptic pruning on synaptic development, we observed dendritic spines and synapses in the mPFC in adulthood. Golgi staining showed that the number of junctions was not significantly diminished (Fig. 3E, F), but the total length of the dendrites of pyramidal neurons was significantly decreased (Fig. 3F), and the spinal density was dramatically lowered in the Sev group (Fig. 3G, H). The number of four kinds of dendritic spines was significantly reduced (Fig. 3H). With TEM, we found the density of excitatory synapses was also dramatically decreased (Fig. 3I, J). These data illustrate that repeated sevoflurane exposure in newborn mice causes over-pruning of excitatory synapses and long-lasting synaptic toxicity in the mPFC.
EPO/EPOR-JAK2-STAT3 Signaling was Inhibited after Repeated Sevoflurane Exposure
We analyzed the transcriptome in the mPFC to determine the intracellular signaling involved in fine motor deficits caused by repeated sevoflurane exposure (Fig. 4A). A total of 197 DEGs (differentially expressed genes) were detected, of which 177 were downregulated and 20 were upregulated (Fig. 4B). Neuroinflammation is the most commonly mentioned mechanism and one of the primary culprits when talking about anesthesia-induced neurodevelopmental impairment [25]. EPOR, a hemoglobin-related gene related to anti-neuroinflammation in the CNS, was identified to be a downregulated gene (Fig. 4C). KEGG (kyoto encyclopedia of Genes and Genomes) analysis showeS1d that EPOR was mainly enriched in the JAK-STAT signal pathway (Fig. 4D). We tested the EPOR expression in microglia (Fig. 4E), neurons (Fig. A) and astrocytes (Fig. S1C) by performing RNAscope in situ hybridization in the mPFC of the Ctl and Sev groups with dual-color staining of neurocyte markers (Iba1, NeuN and S100β) and EPOR mRNA on the 3rd day after repeated exposure to sevoflurane. To determine the degree of EPOR expression in nerve cells after sevoflurane exposure, we calculated the percentage of double-labeled in microglia, neurons, and astrocytes. We found that EPOR was mainly expressed on microglia, followed by neurons, and almost not on astrocytes. After sevoflurane exposure, the microglial EPOR was significantly reduced (Fig. 4F), while the other two did not show significant changes (Fig. S1A-S3D). By using qPCR (quantitative polymerase chain reaction) and WB analyses, we proved that the mRNA and protein levels of EPOR and EPO in the mPFC were lower in the Sev group (Fig. 4G–I). Then, we confirmed the level of peripheral EPO after repeated sevoflurane exposure. According to ELISA analysis, EPO level in the serum was lower in the Sev group (Fig. 4J), while there was no remarkable difference in visceral EPO between the two groups (Fig. S1A). The protein levels of p-JAK2 and p-STAT3 in the mPFC declined (Fig. 4K, L). These data indicate that repeated sevoflurane exposure during the neonatal period inhibits the EPO/EPOR-JAK2-STAT3 signal pathway in the mPFC.
Supplementation of ARA290 Suppresses Microglia Activation and Excessive Pruning of Developmental Synapses
We wondered whether ARA290, a derivative of EPO, could inhibit microglia activation and excessive pruning of developmental synapses induced by repeated sevoflurane exposure. We administered 30 µg/kg ARA290 intraperitoneally due to the widespread use of this dose in mouse studies [26, 27] and our validation (Fig. S1E, F). After ARA290 supplementation, we found smaller soma size, more branch points, longer process length, and more complex branches compared to the Sev-PBS group (Fig. 5B–F). WB analysis displayed that ARA290 supplementation significantly elevated the protein level of arginase-1 (Fig. 5G, H), and significantly decreased iNOS (Fig. 5G–I). Meanwhile, the protein levels of p-JAK2 and p-STAT3 returned to similar levels as the Ctl-PBS group (Fig. 5J, K). The effect of ARA290 supplementation on synaptic pruning of microglia was evaluated via the co-localization of excitatory synapses VGlut2+ with Iba1 (Fig. 5L). After ARA290 supplementation, the synaptic pruning returned to a level similar to the Ctl-PBS group on the 3rd (P11), 7th (P15), and 13th (P21) days (Fig. 5M). Together, these data indicate that ARA290 supplementation inhibits microglia activation and excessive pruning of developmental synapses through the EPO/EPOR-JAK2-STAT3 signal pathway after sevoflurane exposure.
Supplementation of ARA290 Mitigates Long-Lasting Synaptic Toxicity and Fine Motor Defects Caused by Repeated Sevoflurane Exposure
We performed Golgi staining to demonstrate the effect of supplementing ARA290 on long-term synaptic toxicity. The results displayed that the length of the pyramidal neurons' dendrites became longer (Fig. 6B, C), and the spinal density of pyramidal neurons was significantly increased (Fig. 6E, F) after ARA290 supplementation. The number of junctions did not decrease significantly (Fig. 6D), while the number of four kinds of dendritic spines was increased after ARA290 supplementation (Fig. 6G). The density of excitatory synapses detected by TEM returned to a level similar to the Ctl-PBS group (Fig. 6H, I). Then, we evaluated whether supplementation of ARA290 exerted a salvage effect on fine motor dysfunction. Gait analysis showed that the walking speed was significantly increased, including cadence, run average speed, and swing speed (Fig. 6J–L), and the completion and standing time were shortened after ARA290 supplementation (Fig. 6M, N). There were no remarkable differences in other static indicators, including the base of support-front/hind paws, duty cycle, max contact area, mean intensity, and run maximum variation (Fig. S1A–F). The result of the rotarod test displayed a noteworthy increase in the descending latency after supplementing ARA290 (Fig. 6O). Together, these data illustrate that supplementation of ARA290 alleviates long-lasting synaptic toxicity and fine motor dysfunction caused by repeated sevoflurane exposure in neonatal mice.
Discussion
Several well-known clinical trials including MASK, Pediatric Anesthesia Neurodevelopment Assessment (PANDA), and General Anesthesia compared to Spinal anesthesia (GAS) studies elucidate that there is no evident relation between single short exposure of general anesthetics with aberrant neurologic behaviors [28,29,30,31]. Nevertheless, the MASK study that 997 children (411, 380, and 206 un-, singly-, and multiply-exposed, respectively) born in Olmsted County, MN from 1994 to 2007 were sampled using a propensity-guided approach and underwent neuropsychological testing at ages 8–12 or 15–20 years suggests that multiple exposures to general anesthetics is associated with decreased fine motor skills, manifested as descends in processing speed and motor coordination in subjects [8]. Numerous animal studies have also found that general anesthesia induced fine motor deficits [7, 9]. In animal research, methods for studying fine motor skills include the Beam walking test [7], MoRaG test [32], the footprint test [33], the rotarod test [34], and the Catwalk test [35]. The footprint test and Catwalk test have similar principles for gait analysis, but the latter is a new testing device with the advantages of convenient and accurate use. In this study, by using catwalk and rotarod tests, we found that the grew-up mice that were exposed to sevoflurane 3 times in their early stage of life showed fine motor deficits, namely descends in the speed of swing and cadence, as well as extensions in run duration and stand time. These findings were consistent with decreased processing speed in subjects undergoing repeated general anesthesia.
Anesthetic neurotoxicity including fine motor deficits involves diverse mechanisms and cell types, including synaptic changes, myelin sheath injury, and others. Neuroinflammation is an upstream cross-link among them [25]. Microglia are emerging as critical regulators of neuronal function and behavior in nearly every area of neuroscience, especially in neuroinflammation [36]. Recent evidence has demonstrated that pro-inflammatory circumstances triggered synapse remodeling through microglia [37,38,39,40]. Dysfunction of microglia-mediated synaptic pruning during neurodevelopment results in abnormal behaviors in adulthood such as social behaviors [41], Autism spectrum disorder (ASD) [42], and Alzheimer's disease (AD) [43]. The intact fine motor function involves complex coordination between numerous central (the premotor and motor cortex, cerebellum, basal ganglia, and corticospinal tracts) and peripheral nervous system (peripheral nerves, visuospatial, sensory, and executive function processing) structures [44]. Although the cerebellum is vital for the coordination of movement, especially in the initiation of complex pre-planned fine motor movements [45], our study found that there was no significant change in the coordination indicator in the Catwalk assay (Fig. S1A–1E). However, the mice’s processing speed, one of the major components of fine motor control [46], was significantly reduced in our study. Pre-motor and motor cortex, including mPFC, are higher cortical centers that initiate movement [47]. Multiple functional and structural imaging studies have shown that the mPFC plays a very important role in regulating the processing speed of the fine motor skills [16]. Therefore, we focus on the mPFC. Additionally, the proportion of excitatory and inhibitory neurons varies among different brain regions, with 60%–70% of excitatory neurons in the mPFC [48]. In recent years, the microglia-dependent phagocytosis of excitatory synapses has been proposed to occur in many neurological diseases [49,50,51]. Consistently, we found over-pruning of excitatory synapses by microglia in the mPFC in the sevoflurane-exposed mice. Namely, repeated exposure to sevoflurane resulted in microglial morphological alterations and excessive pruning of excitatory synapses by microglia in the mPFC. Whereas transient morphological alterations of microglia, the aberrant microglial function of synaptic phagocytosis was sustained until P21—the optimal period of synaptic pruning [52] in the rodent brain. In our study, Golgi staining showed that the dendritic spine density was decreased in adulthood after repeated exposure to sevoflurane. We and others have shown that both presynaptic components (including SYN and Vglut2, etc.) and postsynaptic components (including Homer and PSD95, etc.) were decreased after exposure to sevoflurane [7, 21, 53,54,55]. Considering some studies demonstrated that sevoflurane can increase dendritic spine density during development [56, 57], we reasoned that excessive pruning of synapses by microglia rather than reduced synaptic formation leads to behavioral changes.
Removing the redundant synapses correctly is important for the normal development and functional homeostasis of the healthy brain, which requires the collaboration of signals modulating synaptic elimination [58]. To reveal the underlying mechanism, we screened out 20 upregulated genes and 177 downregulated genes by RNA Seq (Fig. 5B–D). In the CNS, EPOR is highly expressed in microglia [17] and regulates the morphology and function of microglia to exert anti-neuroinflammatory effects through the EPO/EPOR-JAK2-STAT3 pathway [59]. Therefore, the substantial decrease in EPOR draws our attention. EPO is a hypoxia-inducible factor that is swiftly upregulated when oxygen deficiency occurs [60]. During sevoflurane anesthesia like our study, carrier gas with 60% oxygen in addition to a gas monitor was used to prevent hypoxia. In line with our findings, other literature also reported the EPO/EPOR-inhibitory effect of general anesthesia exposure in the view of anti-apoptosis [61, 62]. It's probably because most of all general anesthetics decrease the cerebral metabolic rate of oxygen. The regulation of EPO lies in hypoxia-inducible factor-1 (HIF-1), which is made up of two subunits HIF-α (containing HIF-1α, HIF-2α, and HIF-3α) and HIF-1β [63]. We detected the expression of HIF-α and found that it was HIF-2α, not HIF-1α (Fig. S1B–D), that was responsible for EPO suppression after repeated sevoflurane exposure. We demonstrated that inhibition of EPO/EPOR-JAK2-STAT3 signaling pathway mediated microglia activation and excessive phagocytosis of synapses after repeated sevoflurane exposure. Our results suggest a new strategy to treat such fine motor disorders by targeting the EPO/EPOR system.
For clinical use, numerous clinical trials as well as “translation-guided” studies considered recombinant human (rh) EPO or ARA290, an EPO derivative, as an efficient treatment for improvements of cognitive performances including learning, memory, attention, executive function, and processing speed [64]. Studies showed that exogenously applied ARA290 exerts neuroprotection without side effects of hematopoiesis and erythropoiesis [65]. Therefore, we selected ARA290 for the treatment of sevoflurane-induced neurotoxicity. Our data showed that at a dose of 30 μg/kg ARA290 effectively restored the activation of the EPOR-JAK2-STAT3 pathway, alleviated aberrant activation and synaptic pruning, and rescued sevoflurane-induced fine motor deficits. Thus, the cumulative evidence supports that EPOR could serve as a potential interventional target for treating sevoflurane-induced neurotoxicity in children.
The following aspects may contribute to the improvement of this study. Firstly, the hypothesis evolves that functional microglial diversity ensures the selective pruning of excitatory versus inhibitory synapses. Several studies have demonstrated that GABA-receptive microglia selectively remodel the inhibitory but not excitatory synapses [52]. An association between microglia and inhibitory synapses, as well as the roles in sevoflurane-induced fine motor deficits, needs to be investigated in further study. Secondly, since EPO is an endogenous hormone that is distributed throughout the body, the causal relationship between EPO alterations in peripheral organs and the brain should be investigated. Thirdly, the role of microglia-specific EPOR in sevoflurane-induced pathological phagocytic functions is still lack of evaluation. Transgene animals and virus targeting on microglial EPOR should be constructed for further exploration.
Conclusions
Based on our findings, we conclude that repeated sevoflurane exposure to the newborn mice induces activation of microglia and excessive synaptic pruning by downregulating EPO/EPOR-JAK2-STAT3 signal pathway in the mPFC, which leads to fine motor deficits in the adult mice. The EPO derivative ARA290 could rescue pathological phagocytosis of microglia and subsequently alleviate sevoflurane-induced fine motor deficits. The graphical abstract is shown in Fig. 6P.
References
Psaty BM, Platt R, Altman RB. Neurotoxicity of generic anesthesia agents in infants and children: An orphan research question in search of a sponsor. JAMA 2015, 313: 1515–1516.
Jiang J, Jiang H. Effect of the inhaled anesthetics isoflurane, sevoflurane and desflurane on the neuropathogenesis of Alzheimer’s disease (review). Mol Med Rep 2015, 12: 3–12.
He B, Wang J. METTL3 regulates hippocampal gene transcription via N6-methyladenosine methylation in sevoflurane-induced postoperative cognitive dysfunction mouse. Aging 2021, 13: 23108–23118.
Satomoto M, Satoh Y, Terui K, Miyao H, Takishima K, Ito M. Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology 2009, 110: 628–637.
Li Y, Zhang L, Wang C, Tang X, Chen Y, Wang X, et al. Sevoflurane-induced learning deficits and spine loss via nectin-1/corticotrophin-releasing hormone receptor type 1 signaling. Brain Res 2019, 1710: 188–198.
Zhong L, Ma X, Niu Y, Zhang L, Xue Z, Yan J, et al. Sevoflurane exposure may cause dysplasia of dendritic spines and result in fine motor dysfunction in developing mouse through the PI3K/AKT/mTOR pathway. Front Neurosci 2022, 16: 1006175.
Zhang L, Cheng Y, Xue Z, Li J, Wu N, Yan J, et al. Sevoflurane impairs m6A-mediated mRNA translation and leads to fine motor and cognitive deficits. Cell Biol Toxicol 2022, 38: 347–369.
Zaccariello MJ, Frank RD, Lee M, Kirsch AC, Schroeder DR, Hanson AC, et al. Patterns of neuropsychological changes after general anaesthesia in young children: Secondary analysis of the Mayo Anesthesia Safety in Kids study. Br J Anaesth 2019, 122: 671–681.
Ing C, Warner DO, Sun LS, Flick RP, Davidson AJ, Vutskits L, et al. Anesthesia and developing brains: Unanswered questions and proposed paths forward. Anesthesiology 2022, 136: 500–512.
Clausen NG, Venø S, Astvad M, Henneberg SW, Christensen K, Hansen TG. Potential neurotoxicity of general anaesthetics to the developing brain. Ugeskr Laeger 2014, 176: V12120689.
Li T, Huang Z, Wang X, Zou J, Tan S. Role of the GABAA receptors in the long-term cognitive impairments caused by neonatal sevoflurane exposure. Rev Neurosci 2019, 30: 869–879.
Xu F, Han L, Wang Y, Deng D, Ding Y, Zhao S, et al. Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors. BMC Med 2023, 21: 7.
Zheng ZH, Tu JL, Li XH, Hua Q, Liu WZ, Liu Y, et al. Neuroinflammation induces anxiety- and depressive-like behavior by modulating neuronal plasticity in the basolateral amygdala. Brain Behav Immun 2021, 91: 505–518.
Socodato R, Henriques JF, Portugal CC, Almeida TO, Tedim-Moreira J, Alves RL, et al. Daily alcohol intake triggers aberrant synaptic pruning leading to synapse loss and anxiety-like behavior. Sci Signal 2020, https://doi.org/10.1126/scisignal.aba5754.
Brennan AR, Arnsten AFT. Neuronal mechanisms underlying attention deficit hyperactivity disorder: The influence of arousal on prefrontal cortical function. Ann N Y Acad Sci 2008, 1129: 236–245.
Arnsten AFT. The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder. Expert Rev Neurother 2010, 10: 1595–1605.
Tamura T, Aoyama M, Ukai S, Kakita H, Sobue K, Asai K. Neuroprotective erythropoietin attenuates microglial activation, including morphological changes, phagocytosis, and cytokine production. Brain Res 2017, 1662: 65–74.
Brines M, Patel NSA, Villa P, Brines C, Mennini T, De Paola M, et al. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A 2008, 105: 10925–10930.
Swartjes M, van Velzen M, Niesters M, Aarts L, Brines M, Dunne A, et al. ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response. Mol Pain 2014, 10: 13.
Timotius IK, Roelofs RF, Richmond-Hacham B, Noldus LPJJ, von Hörsten S, Bikovski L. CatWalk XT gait parameters: A review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models. Front Behav Neurosci 2023, 17: 1147784.
Liang L, Zeng T, Zhao Y, Lu R, Guo B, Xie R, et al. Melatonin pretreatment alleviates the long-term synaptic toxicity and dysmyelination induced by neonatal Sevoflurane exposure via MT1 receptor-mediated Wnt signaling modulation. J Pineal Res 2021, 71: e12771.
Knaus LS, Basilico B, Malzl D, Gerykova Bujalkova M, Smogavec M, Schwarz LA, et al. Large neutral amino acid levels tune perinatal neuronal excitability and survival. Cell 2023, 186: 1950-1967.e25.
Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol 2014, 32: 367–402.
Schafer DP, Lehrman EK, Stevens B. The, “quad-partite” synapse: Microglia-synapse interactions in the developing and mature CNS. Glia 2013, 61: 24–36.
Niu Y, Yan J, Jiang H. Anesthesia and developing brain: What have we learned from recent studies. Front Mol Neurosci 2022, 15: 1017578.
Watanabe M, Lundgren T, Saito Y, Cerami A, Brines M, Östenson CG, et al. A nonhematopoietic erythropoietin analogue, ARA 290, inhibits macrophage activation and prevents damage to transplanted islets. Transplantation 2016, 100: 554–562.
Al-Onaizi MA, Thériault P, Lecordier S, Prefontaine P, Rivest S, ElAli A. Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression. Brain Behav Immun 2022, 99: 363–382.
Warner DO, Zaccariello MJ, Katusic SK, Schroeder DR, Hanson AC, Schulte PJ, et al. Neuropsychological and behavioral outcomes after exposure of young children to procedures requiring general anesthesia: The mayo anesthesia safety in kids (MASK) study. Anesthesiology 2018, 129: 89–105.
Sun LS, Li G, Miller TLK, Salorio C, Byrne MW, Bellinger DC, et al. Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood. JAMA 2016, 315: 2312–2320.
Davidson AJ, Disma N, de Graaff JC, Withington DE, Dorris L, Bell G, et al. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): An international multicentre, randomised controlled trial. Lancet 2016, 387: 239–250.
McCann ME, de Graaff JC, Dorris L, Disma N, Withington D, Bell G, et al. Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): An international, multicentre, randomised, controlled equivalence trial. Lancet 2019, 393: 664–677.
Dubos A, Meziane H, Iacono G, Curie A, Riet F, Martin C, et al. A new mouse model of ARX dup24 recapitulates the patients’ behavioral and fine motor alterations. Hum Mol Genet 2018, 27: 2138–2153.
Carter RJ, Morton J, Dunnett SB. Motor coordination and balance in rodents. Curr Protoc Neurosci 2001, Chapter 8: Unit8.12.
Gao C, Qian Y, Huang J, Wang D, Su W, Wang P, et al. A three-day consecutive fingolimod administration improves neurological functions and modulates multiple immune responses of CCI mice. Mol Neurobiol 2017, 54: 8348–8360.
Mészáros L, Riemenschneider MJ, Gassner H, Marxreiter F, von Hörsten S, Hoffmann A, et al. Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy. Acta Neuropathol Commun 2021, 9: 68.
Woodburn SC, Bollinger JL, Wohleb ES. The semantics of microglia activation: Neuroinflammation, homeostasis, and stress. J Neuroinflammation 2021, 18: 258.
Kettenmann H, Kirchhoff F, Verkhratsky A. Microglia: New roles for the synaptic stripper. Neuron 2013, 77: 10–18.
Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science 2011, 333: 1456–1458.
Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74: 691–705.
Wang M, Jiang Y, Huang Z. Loss of C9orf72 in microglia drives neuronal injury by enhancing synaptic pruning in aged and Alzheimer’s disease mice. Neurosci Bull 2022, 38: 327–330.
Kim HJ, Cho MH, Shim WH, Kim JK, Jeon EY, Kim DH, et al. Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects. Mol Psychiatry 2017, 22: 1576–1584.
Edmonson CA, Ziats MN, Rennert OM. A non-inflammatory role for microglia in autism spectrum disorders. Front Neurol 2016, 7: 9.
Hong S, Dissing-Olesen L, Stevens B. New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016, 36: 128–134.
Burr P, Choudhury P. Fine motor disability. StatPearls 2022
Manto M, Bower JM, Conforto AB, Delgado-García JM, da Guarda SNF, Gerwig M, et al. Consensus paper: Roles of the cerebellum in motor control—the diversity of ideas on cerebellar involvement in movement. Cerebellum 2012, 11: 457–487.
Allgöwer K, Hermsdörfer J. Fine motor skills predict performance in the Jebsen Taylor Hand Function Test after stroke. Clin Neurophysiol 2017, 128: 1858–1871.
Khaku AS, Tadi P. Cerebrovascular Disease. StatPearls 2023
Chen A, Sun Y, Lei Y, Li C, Liao S, Meng J, et al. Single-cell spatial transcriptome reveals cell-type organization in the macaque cortex. Cell 2023, 186: 3726-3743.e24.
Soteros BM, Sia GM. Complement and microglia dependent synapse elimination in brain development. WIREs Mech Dis 2022, 14: e1545.
Dong X, Fan J, Lin D, Wang X, Kuang H, Gong L, et al. Captopril alleviates epilepsy and cognitive impairment by attenuation of C3-mediated inflammation and synaptic phagocytosis. J Neuroinflammation 2022, 19: 226.
Wang J, Chen HS, Li HH, Wang HJ, Zou RS, Lu XJ, et al. Microglia-dependent excessive synaptic pruning leads to cortical underconnectivity and behavioral abnormality following chronic social defeat stress in mice. Brain Behav Immun 2023, 109: 23–36.
Favuzzi E, Huang S, Saldi GA, Binan L, Ibrahim LA, Fernández-Otero M, et al. GABA-receptive microglia selectively sculpt developing inhibitory circuits. Cell 2021, 184: 5686.
Lv JM, Zhang LM, Wang JX, Shao JJ, Guo XG, Wang LY, et al. Abdominal surgery plus sevoflurane exposure induces abnormal emotional changes and cognitive dysfunction in aged rats. Behav Brain Res 2023, 442: 114328.
Xu G, Lu H, Dong Y, Shapoval D, Soriano SG, Liu X, et al. Coenzyme Q10 reduces sevoflurane-induced cognitive deficiency in young mice. Br J Anaesth 2017, 119: 481–491.
Zheng H, Dong Y, Xu Z, Crosby G, Culley DJ, Zhang Y, et al. Sevoflurane anesthesia in pregnant mice induces neurotoxicity in fetal and offspring mice. Anesthesiology 2013, 118: 516–526.
Briner A, De Roo M, Dayer A, Muller D, Habre W, Vutskits L. Volatile anesthetics rapidly increase dendritic spine density in the rat medial prefrontal cortex during synaptogenesis. Anesthesiology 2010, 112: 546–556.
Useinovic N, Near M, Cabrera OH, Boscolo A, Milosevic A, Harvey R, et al. Neonatal sevoflurane exposure induces long-term changes in dendritic morphology in juvenile rats and mice. Exp Biol Med 2023, 248: 641–655.
Lehrman EK, Wilton DK, Litvina EY, Welsh CA, Chang ST, Frouin A, et al. CD47 protects synapses from excess microglia-mediated pruning during development. Neuron 2018, 100: 120-134.e6.
Wei S, Luo C, Yu S, Gao J, Liu C, Wei Z, et al. Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway. Exp Cell Res 2017, 361: 342–352.
Haase VH. Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev 2013, 27: 41–53.
Tanaka T, Kai S, Koyama T, Daijo H, Adachi T, Fukuda K, et al. General anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain. PLoS One 2011, 6: e29378.
Kai S, Tanaka T, Matsuyama T, Suzuki K, Hirota K. The volatile anesthetic isoflurane differentially suppresses the induction of erythropoietin synthesis elicited by acute anemia and systemic hypoxemia in mice in an hypoxia-inducible factor-2-dependent manner. Eur J Pharmacol 2014, 732: 43–49.
Shah YM, Xie L. Hypoxia-inducible factors link iron homeostasis and erythropoiesis. Gastroenterology 2014, 146: 630–642.
Robertson CS, Garcia R, Gaddam SSK, Grill RJ, Cerami Hand C, Tian TS, et al. Treatment of mild traumatic brain injury with an erythropoietin-mimetic peptide. J Neurotrauma 2013, 30: 765–774.
Sanchis-Gomar F, Perez-Quilis C, Lippi G. Erythropoietin receptor (EpoR) agonism is used to treat a wide range of disease. Mol Med 2013, 19: 62–64.
Acknowledgments
We are grateful to all the staff in the Department of Neurobiology and Institute of Neurosciences of Fourth Military Medical University for their support and help during the experiments. This work was supported by grants from the National Natural Science Foundation of China (82101534, 82171170, and 82201414), the Natural Science Foundation of Shaanxi Provence (2024JCYBMS659), and the Science and Technology Plan in Xi’an of China (23YXYJ0134).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All authors claim that there are no potential conflicts of interest for the research, authorship, and publication of this article.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
He, D., Shi, X., Liang, L. et al. Microglial EPOR Contribute to Sevoflurane-induced Developmental Fine Motor Deficits Through Synaptic Pruning in Mice. Neurosci. Bull. (2024). https://doi.org/10.1007/s12264-024-01248-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12264-024-01248-5